AAIC 2025 Abstract
TRanslational Initiative to DE‐risk NeuroTherapeutics (TRIDENT) – A revolutionary pre‐clinical approach to maximize the predictive validity of pre‐clinical evaluation
Abstract
Background: Neurodegenerative diseases such as Alzheimer's Disease (AD), Frontotemporal Dementia (FTD), Dementia with Lewy Bodies (DLB), Parkinson's Disease (PD), and Multiple System Atrophy (MSA), are complex and poorly understood conditions characterized by progressive neuronal degeneration, affecting brain structure
